NYSE:GMEDMedical Equipment
Globus Medical’s Strong Q2 and Buyback Might Change The Case For Investing In GMED
Globus Medical reported strong second-quarter 2025 results, with sales of US$745.34 million and net income of US$202.85 million, along with reaffirmed full-year revenue guidance of US$2.80 billion to US$2.90 billion.
The company completed a share buyback of 411,000 shares for US$24.99 million, signaling ongoing confidence in its capital allocation strategy.
We’ll now explore how Globus Medical’s robust earnings growth and reaffirmed guidance influence its broader investment narrative.
We've...